Lpl Financial LLC Akebia Therapeutics, Inc. Transaction History
Lpl Financial LLC
- $196 Billion
- Q2 2024
A detailed history of Lpl Financial LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 58,032 shares of AKBA stock, worth $77,182. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,032
Previous 17,845
225.2%
Holding current value
$77,182
Previous $32,000
84.38%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding AKBA
# of Institutions
110Shares Held
55.3MCall Options Held
554KPut Options Held
246K-
Black Rock Inc. New York, NY11.6MShares$15.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.28MShares$12.3 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$7.64 Million11.5% of portfolio
-
Geode Capital Management, LLC Boston, MA4.54MShares$6.03 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA4.06MShares$5.4 Million0.01% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $245M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...